Potomac horse fever isolates

US9339532B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9339532-B2
Application numberUS-201314101659-A
CountryUS
Kind codeB2
Filing dateDec 10, 2013
Priority dateAug 30, 2010
Publication dateMay 17, 2016
Grant dateMay 17, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention discloses novel isolates of Neorickettsia risticii , compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising a N. risticii Michigan isolate having the ATCC deposit number PTA-11404; wherein the N. risticii is killed or inactivated. 2. The composition of claim 1 wherein the N. risticii is killed or inactivated by a method selected from the group comprising sonication, freeze-thaw techniques, pressure, treatment with heat, a chemical and an enzyme. 3. The composition of claim 2 wherein the chemical is selected from the group consisting of binary ethyleneimine and formalin.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9339532B2 cover?
The present invention discloses novel isolates of Neorickettsia risticii , compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
Who is the assignee on this patent?
Intervet Inc
What technology area does this patent fall under?
Primary CPC classification A61K39/0233. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).